Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TVGNthis companyTevogen Bio Holdings Inc.	$5.87	-2.05×	-6.68×	0×	-2.25×	-130.0%	0.0%	0.0%	0.0%	319.1%	3698.7%	-22.5%	-0.38×	-0.1×	-133.63×	0.22×	0.0%	3	-59.67	2	C
ATOSAtossa Therapeutics, Inc.	$2.13	-2.19×	1.94×	0×	-1×	88.9%	0.0%	0.0%	0.0%	-88.4%	-94.4%	-39.1%	0×	1.19×	0×	5.53×	0.0%	1	-11.86	2	B-
CGTXCognition Therapeutics, Inc.	$0.70	-4.22×	2.87×	0×	-2.67×	-14.9%	0.0%	0.0%	0.0%	-68.5%	-136.9%	-25.0%	0.02×	1.56×	-3,676.85×	3.45×	0.0%	1	-0.97	2	C+
CLNNClene Inc.	$4.84	-2.22×	-3.29×	289.36×	-3.38×	-148.3%	78.5%	-11541.5%	-13086.5%	148.8%	-188.6%	-32.1%	-1.23×	-0.75×	-8.61×	0.83×	0.0%	2	-23.05	2	C
GLSIGreenwich LifeSciences, Inc.	$16.70	-14.69×	805.09×	0×	-14.37×	-99.2%	0.0%	0.0%	0.0%	-5480.5%	-5505.9%	-3.5%	0×	0.32×	0×	1.06×	0.0%	1	2.27	1	D+
HURATuHURA Biosciences, Inc.	$1.70	-1.2×	1.73×	0×	-1.14×	-100.8%	0.0%	0.0%	0.0%	-143.6%	-145.7%	-76.4%	0.03×	0.1×	-50.85×	0.78×	0.0%	1	-5.35	2	C
Peer median	—	-2.22×	1.94×	0×	-2.67×	-99.2%	0.0%	0.0%	0.0%	-88.4%	-145.7%	-32.1%	0×	0.32×	-8.61×	1.06×	0.0%	1	-5.35	2	—